LILLY SAYS FDA TO HOLD MEETING OF OUTSIDE ADVISERS ON SAFETY AND EFFICACY OF DONANEMAB, NO DATE SET
Stock Market News
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,882 PTS | -1.15% | -1.62% | - | ||
905.6 USD | -3.82% | -3.64% | 815B | ||
- Stock Market
- Stock Market News
- Economy
- Lilly Says Fda To Hold Meeting Of Outside Advisers On Safety And…